| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| enGene Holdings Inc. | Director | Stock Option (Right to Buy) | 22,500 | 16 Jun 2025 | Direct | ||
| Vor Biopharma Inc. | Director | Stock Option (Right to Buy) | 3,000 | 18 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VOR | Vor Biopharma Inc. | 18 Dec 2025 | 1 | $0 | 4 | Director | 19 Dec 2025, 18:17 |
| VOR | Vor Biopharma Inc. | 18 Dec 2025 | 0 | $0 | 3 | Director | 19 Dec 2025, 18:07 |
| ENGN | enGene Holdings Inc. | 16 Jun 2025 | 1 | $0 | 4 | Director | 16 Jun 2025, 18:39 |
| NAMS | NewAmsterdam Pharma Co N.V. | 16 Jul 2024 | 0 | $0 | 3 | Director | 19 Jul 2024, 16:30 |
| ENGN | enGene Holdings Inc. | 15 Jun 2024 | 1 | $0 | 4 | Director | 18 Jun 2024, 16:08 |
| ENGN | enGene Holdings Inc. | 15 May 2024 | 0 | $0 | 3 | Director | 17 May 2024, 17:19 |
| /report/000095010321019586-joustra-wouter-2021-12-09 | Forbion European Acquisition Corp. | 09 Dec 2021 | 0 | $0 | 3 | Director | 09 Dec 2021, 16:49 |